Evidence map›Paper›PMID 29480793›Full record

ArticleZebrafish2018

The Efficacy of Puromycin and Adriamycin for Induction of Glomerular Failure in Larval Zebrafish Validated by an Assay of Glomerular Permeability Dynamics.

Sebastien Andrew Rider, Finnius Austin Bruton, Richard George Collins, Bryan Ronald Conway, John James Mullins

Open access · hybridAbstract readValidation Study
In one paragraph

Article in Zebrafish, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Reduced α-galactosidase A activity in zebrafish (Molecular genetics and metabolism reports · 2022
    Article
  4. Review
  5. Use of Zebrafish in Drug Discovery Toxicology.Chemical research in toxicology · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sebastien Andrew Rider1 Univeristy/BHF Centre for Cardiovascular Science, The Queen's Medical Research Institute, Little France, The University of Edinburgh , Edinburgh, United Kingdom .
Finnius Austin Bruton1 Univeristy/BHF Centre for Cardiovascular Science, The Queen's Medical Research Institute, Little France, The University of Edinburgh , Edinburgh, United Kingdom .
Richard George Collins2 Edinburgh College of Art, University of Edinburgh , Edinburgh, United Kingdom .
Bryan Ronald Conway1 Univeristy/BHF Centre for Cardiovascular Science, The Queen's Medical Research Institute, Little France, The University of Edinburgh , Edinburgh, United Kingdom .
John James Mullins1 Univeristy/BHF Centre for Cardiovascular Science, The Queen's Medical Research Institute, Little France, The University of Edinburgh , Edinburgh, United Kingdom .
The Queen's Medical Research Institute · GBUniversity of Edinburgh · GB

Funding

British Heart FoundationWellcome Trust WT104915MA
6 · The paper itself

Abstract

Defects in the glomerular filtration barrier (GFB) play a major role in the onset of human renal diseases. Highly ramified glomerular cells named podocytes are a critical component of the GFB. Injury to podocytes results in abnormal excretion of plasma proteins, which can lead to chronic kidney disease. The conserved paired nephron of larval zebrafish is an excellent model for assessing glomerular function and injury. The efficacy of two known podocyte toxins was tested to refine models of acute podocyte injury in larval zebrafish. The validated compound was then used to test a novel assay of the dynamics of abnormal protein excretion. Injected adriamycin was found to be unsuitable for induction of glomerular injury due to off-target cardiovascular toxicity. In contrast, puromycin treatment resulted in a loss of discriminative filtration, measured by excretion of 70 kDa dextran, and podocyte effacement confirmed by electron microscopy. The dynamics of dextran excretion during puromycin injury modeled the onset of glomerular damage within 24 hours postinjection. These data validate puromycin for induction of acute podocyte injury in zebrafish larvae and describe a semihigh-throughput assay for quantifying the dynamics of abnormal protein excretion.

Indexed as

AnimalsAntibiotics, AntineoplasticAntimetabolites, AntineoplasticCell Membrane PermeabilityDextransDoxorubicinGlomerular Filtration BarrierKidney GlomerulusLarvaProteinuriaPuromycinZebrafishZebrafish ProteinsAntibiotics, AntineoplasticAntimetabolites, AntineoplasticDextransDoxorubicinPuromycinZebrafish Proteinsadriamycinglomeruluskidneypharmacologicalpodocytepuromycin

Identifiers

PMID29480793
PMCPMC5985910
OpenAlexW2793837636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.